Botox has been approved by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for the treatment of ankle disability due to lower limb spasticity associated with stroke in adults.
Joe Korner, at the Stroke Association, said: “There can be significant advantages in using Botox to treat people whose movement and walking ability have been affected by stroke. Up to 30% of stroke survivors are living with post-stroke spasticity. This painful condition can cause a devastating loss of independence.”
